Search Results

Plerixafor octahydrochloride 200 mg  | Purity Not Available

TargetMol

AMD 3100 octahydrochloride blocks the binding of stromal cell-derived factor (SDF-1alpha) to the cellular receptor CXCR4, resulting in hematopoietic stem cell (HSC) release from bone marrow and HSC movement into the peripheral circulation. Plerixafor is a bicyclam with hematopoietic stem cell-mobilizing activity.

More Information Supplier Page

Plerixafor octahydrochloride 25 mg  | Purity Not Available

TargetMol

AMD 3100 octahydrochloride blocks the binding of stromal cell-derived factor (SDF-1alpha) to the cellular receptor CXCR4, resulting in hematopoietic stem cell (HSC) release from bone marrow and HSC movement into the peripheral circulation. Plerixafor is a bicyclam with hematopoietic stem cell-mobilizing activity.

More Information Supplier Page

Raloxifene hydrochloride 200 mg  | 99.56%

TargetMol

Raloxifene hydrochloride is a second generation selective estrogen receptor modulator (SERM) used to prevent osteoporosis in postmenopausal women. It has estrogen agonist effects on bone and cholesterol metabolism but behaves as a complete estrogen antagonist on mammary gland and uterine tissue.

More Information Supplier Page

Drospirenone 200 mg  | 99.85%

TargetMol

Drospirenone is a synthetic spironolactone analogue and progestin with progestational and anti-mineralocorticoid activity.

More Information Supplier Page

Drospirenone 50 mg  | 99.85%

TargetMol

Drospirenone is a synthetic spironolactone analogue and progestin with progestational and anti-mineralocorticoid activity.

More Information Supplier Page

Drospirenone 10 mg  | 99.85%

TargetMol

Drospirenone is a synthetic spironolactone analogue and progestin with progestational and anti-mineralocorticoid activity.

More Information Supplier Page